Skip to main content
TipRanks
Go Ultimate75% OFF

Sunny Pharmtech Inc. (6676) Financial Statements

Sunny Pharmtech Inc. Financial Overview

Sunny Pharmtech Inc.'s market cap is currently NT$1.28B. The company's EPS TTM is NT$-2.14; its P/E ratio is -3.27; Sunny Pharmtech Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 253.01MNT$ 418.01MNT$ 428.83MNT$ 359.58MNT$ 241.00M
Gross ProfitNT$ -23.37MNT$ 226.40MNT$ 285.53MNT$ 206.71MNT$ 115.75M
Operating IncomeNT$ -317.53MNT$ -162.99MNT$ -72.10MNT$ -187.62MNT$ -176.00M
EBITDANT$ -189.95MNT$ -23.91MNT$ 69.14MNT$ -53.96MNT$ -64.31M
Net IncomeNT$ -302.05MNT$ -156.00MNT$ -63.32MNT$ -170.24MNT$ -174.79M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 54.87MNT$ 141.12MNT$ 277.66MNT$ 289.74MNT$ 284.99M
Total AssetsNT$ 1.40BNT$ 1.59BNT$ 1.71BNT$ 1.63BNT$ 1.59B
Total DebtNT$ 484.37MNT$ 386.30MNT$ 391.43MNT$ 562.68MNT$ 366.33M
Net DebtNT$ 432.61MNT$ 248.27MNT$ 120.87MNT$ 340.05MNT$ 137.33M
Total LiabilitiesNT$ 647.82MNT$ 540.68MNT$ 512.44MNT$ 660.32MNT$ 468.26M
Stockholders' EquityNT$ 754.95MNT$ 1.05BNT$ 1.20BNT$ 969.30MNT$ 1.13B
Cash Flow
Free Cash FlowNT$ -188.31MNT$ -86.58MNT$ -107.09MNT$ -168.41MNT$ -194.87M
Operating Cash FlowNT$ -158.99MNT$ -37.10MNT$ 38.10MNT$ 26.88MNT$ -34.35M
Investing Cash FlowNT$ -38.17MNT$ -85.22MNT$ -85.85MNT$ -221.63MNT$ -213.79M
Financing Cash FlowNT$ 106.90MNT$ -10.21MNT$ 95.67MNT$ 188.38MNT$ 235.43M

Currency in TWD

Sunny Pharmtech Inc. Earnings and Revenue History

-400M0400M800M-1500 %-1000 %-500 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Sunny Pharmtech Inc. Liabilities to Assets

0600M1.2B1.8B0 %20 %40 %60 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Sunny Pharmtech Inc. Cash Flow

-500M-250M0250M500M750M201720182019202020212022202320242025OperatingInvestingFinancing

Sunny Pharmtech Inc. Forecast EPS vs Actual EPS